Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

237
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
12/16/2014 12/17/2014 12/18/2014 12/19/2014 12/22/2014 Date
112.3(c) 112.1(c) 115(c) 114(c) 115.4(c) Last
4 664 540 2 553 822 3 532 904 5 279 633 1 841 643 Volume
+2.93% -0.18% +2.59% -0.87% +1.23% Change
More quotes
Company
Bayer AG is engaged in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
02/26Earnings Release
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 41 798 M
EBIT 2014 6 399 M
Net income 2014 3 846 M
Debt 2014 16 343 M
Yield 2014 1,96%
Sales 2015 45 469 M
EBIT 2015 7 333 M
Net income 2015 4 541 M
Debt 2015 15 284 M
Yield 2015 2,20%
PER 2014 24,62
PER 2015 21,28
EV / Sales 2014 2,65x
EV / Sales 2015 2,41x
Capitalization 94 272 M
More Financials
Latest news on BAYER AG
9h ago BAYER : Syringes and tubing for Medrad injectors
21h ago BAYER : X-Chem Licenses Drug Discovery Program to Bayer Pharma AG
4d ago BAYER : to divest equine assets to Merial; Divestiture includes Legend /Hyonate ..
5d agoDJBayer Plans to Sell Equine-Health Products to Sanofi Unit
5d ago BAYER : to divest equine assets to Merial -- Divestiture includes Legend® /Hyona..
12/15 NATCO PHARMA : Apex court quashes bayer's plea on nexavar licence
12/12 BAYER : strives to improve lives with innovative products
12/09DJMerck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 6th Update
More news
Sector news
3h ago M&A boom helps push investment banking fees to highest level since 2007
3h ago EXPRESS SCRIPTS : alters financial landscape for drugs
4h ago EXPRESS SCRIPTS : Business Highlights
More sector news
4-Traders Strategies on BAYER AG 
07/18The EUR 100 area as entry point
05/20The EUR 104 resistance as main obstacle
More Strategies


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF